Related Experiment Video
Updated: Nov 1, 2025

08:15
Use of High-Throughput Automated Microbioreactor System for Production of Model IgG1 in CHO Cells
Published on: September 28, 2018
11.2K
Generic and specific recurrent neural network models: Applications for large and small scale biopharmaceutical
Jens Smiatek1,2, Christoph Clemens3, Liliana Montano Herrera4
1Institute for Computational Physics, University of Stuttgart, D-70569 Stuttgart, Germany.
Biotechnology Reports (Amsterdam, Netherlands)
|June 23, 2021
Summary
Recurrent neural network (RNN) models accurately predict upstream bioprocess parameters, offering a powerful tool for process control and development. These models demonstrate significant predictive capabilities, outperforming experimental variability.
Area of Science:
- Biotechnology and Bioprocessing
- Computational Biology
- Chemical Engineering
Background:
- Accurate estimation of time-varying upstream process outcomes is crucial but challenging.
- Existing parametric, semi-parametric, and non-parametric methods have limitations in reliability and applicability.
- Recurrent neural networks (RNNs) offer a potential solution for complex bioprocess modeling.
Purpose of the Study:
- To develop and evaluate generic and product-specific RNN models for calculating upstream process parameters.
- To assess the temporal evolution of growth and metabolite-related parameters.
- To demonstrate the utility of RNNs for both large-scale manufacturing and early-stage development.
Main Methods:
- Implementation of generic and product-specific recurrent neural network (RNN) models.
- Application of models for computing growth and metabolite-related upstream process parameters and their temporal dynamics.
- Validation of model accuracy against experimental data, including root-mean squared error of prediction analysis.
Main Results:
- RNN models achieved high accuracy in predicting product titer and other upstream outcomes compared to experimental data.
- Calculated root-mean squared errors of prediction were significantly lower than experimental standard deviations.
- A generic RNN model successfully simulated process outcomes under varying temperatures for platform processes.
Conclusions:
- RNN models provide a highly accurate and broadly applicable approach for upstream bioprocess monitoring and control.
- The straightforward implementation and high predictive capability make RNNs a promising alternative to traditional methods.
- RNNs offer significant benefits for process development, scale-up, and manufacturing, particularly for platform processes.

